Member Alert: January 30, 2018
International Academy of Compounding Pharmacists (IACP) Urges Congress to Protect Patient Access to Compounded Medications
IACP Vice President Shawn Hodges, PharmD Serves as Witness
for Pharmacy Compounding at E&C Health Subcommittee Hearing
The International Academy of Compounding Pharmacists (IACP) testified today before the U.S. House of Representatives’ Energy & Commerce’s Health Subcommittee
Hearing on pharmacy compounding, “Examining Implementation of the Compounding Quality Act.” The Subcommittee on Health is chaired by U.S. Congressman Michael C. Burgess, MD (TX).
IACP Vice President Shawn Hodges, PharmD , served as a witness representing 503A compounding pharmacies at today’s Congressional hearing. Dr. Hodge’s written testimony submitted to the Congressional Health Subcommittee can be viewed in its entirety here.
On behalf of the IACP Board of Directors, we thank Shawn Hodges for his willingness and dedication to serve our patients, and our profession, at this hearing.
Excerpt from Dr. Hodge’s Testimony
“Every day, compounding pharmacists serve patients in a variety of areas including: autism, oncology, dermatology and pediatrics, in a variety of practice settings including hospice in-patient units, emergency rooms, surgical centers, physician clinics, and even Federal Facilities like the VA. Compounding pharmacists also have served patients such as pre-term infants who require parenteral nutrition (PN). PN provides intravenous lifesaving therapy for patients whose gastrointestinal (GI) tracts are not functioning or cannot be accessed, or where nutritional needs cannot be met with oral or enteral diets. These are just a few examples of how compounding pharmacists are working with physicians to provide life-saving medications for patients.”
Dr. Hodge’s written testimony submitted to the Congressional Health Subcommittee can be viewed in its entirety here.
View Witness List and Background Materials
Please click here to view the complete witness list for today’s hearing.
View IACP’s Press Release on Today’s Hearing
Please click here for IACP’s press release.
E&C Health Subcommittee Hearing Recording
PLEASE NOTE: For those who were not able to view the hearing, we will provide a link to the Subcommittee’s recording as soon as available.
Thank you to our Members of Congress for Supporting our Patients’ Access to Compounded Medications
Thank you to U.S. Members of Congress including: Congressman Morgan Griffith (VA), Congressman Buddy Carter (GA) and Congressman Michael Burgess, MD (TX) who mentioned today the value and necessity of compounded medications.
Please note: we will provide the final hearing transcript as soon as available.
Thank you to our DQSA Coalition Colleagues – American Academy of Dermatology Association, American Academy of Ophthalmology & National Community Pharmacists Association – Hearing Panel Participants
(l to r): IACP Vice President Shawn Hodges, PharmD; Jacob Olson, President and CEO, Skywalk Pharmacy, on behalf of National Community Pharmacists Association; George Williams, MD, President Elect, American Academy of Ophthalmology; and Bruce Brod, MD, Chair, Congressional Policy Committee, American Academy of Dermatology Association
Thank you IACP Members for providing testimonials on how pharmacy compounding makes a huge difference for patients. We urge all IACP members and their patients, and providers to become Partnership for Personalized Prescriptions (P3) advocates! Please continue to share your patient stories on the P3 website, and encourage your patients and providers to do the same.
IACP is working on your patients’ behalf to protect access to compounded medications! This hearing was a critical opportunity to present the value & necessity compounded medications bring for patients and the providers who serve them.
Please email IACP with questions or comments at [email protected]. We will make you aware of any continuing developments.